DOI: 10.21045/2071-5021-2016-49-3-8

A.V. Vladimirov
Khanty-Mansijsk TB Hospital, Khanty Mansijsk

Contacts: Aleksandr V. Vladimirov, e-mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Abstract

High prevalence of TB-HIV co-infection principally changes epidemiologic situation dramatically affecting levels and structure of infectious mortality.

Purpose: to study mortality dynamics from TB and HIV in Khanty-Mansi autonomous area - Yugra in late XX and early XXI centuries.

Methods and data: data of the Federal State Statistics Service on population mortality in Khanty-Mansijsk autonomous area (standardized rate per 100,000 population) from TB, HIV and infectious diseases in 1996-2014 as well as population number by age and sex.

Results. In 1996-2014, average rates of TB mortality in both males and females in Khanty-Mansijsk autonomous area - Yugra moved to older ages reaching their maximum in age group over 55 years. Dynamics of HIV mortality in early XXI century suggests its unprecedented growth in ages 20-34 and 35-44 years (up to 34.9 and 61.7 per 100,000) conditioned by mortality growth in patients with TB and HIV co-infection. At late XX century and early XXI century in children 0-14 years and adolescents 15-19 years deaths from TB and HIV were sporadic. Within the same period in older age groups (over 45) we observed annual reduction in mortality from TB at the background of low HIV mortality. To reduce HIV mortality it is necessary to introduce comprehensive organizational measures that require a close cooperation between TB services and the AIDS Center.

Keywords: mortality; TB; HIV; TB-HIV co-infection.

References

1. Lechenie tuberkuleza: rekomendatsii. 4-e izdanie [Treatment of tuberculosis. Guidelines. 4-edition]. WHO Regional office for Europe. Geneva; 2011. 183 p. [Online] [cited 2016 Apr 04]. Available from: http:// whqlibdoc.who.int/publications/2011/9789244547830_rus.pdf (In Russian)
2. Mezhdunarodnaya statisticheskaya klassifikatsiya bolezney i problem, svyazannykh so zdorov'em. Sbornik instruktsiy Desyatyy peresmotr.[International statistical classification of diseases and health related problems. Collection of instructions. 10-th review]. Geneva: WHO; 1995; Vol. 2, 179 p. (In Russian)
3. Rukovodyashchie printsipy dlya intensivnogo vyyavleniya tuberkuleza i profilakticheskoy terapii izoniazidom u lyudey, zhivushchikh s VICh, v usloviyakh nekhvatki resursov [Guidelines for intensive tuberculosis detection and isoniazid preventive therapy for people living with HIV in resource limited settings]. WHO. Geneva, 2011. 39 p. [Online] [cited 2016 Apr 04]. Available from: http://apps.who.int/iris/bitstream/10665/44472/1/9789241500708_eng.pdf (In Russian)
4. Tsybikova E.B., Vladimirov A.V. Smertnost' ot tuberkuleza i VICh-infektsii v raznykh vozrastno-polovykh gruppakh naseleniya v Rossii v nachale XXI veka [The death rate caused by tuberculosis and HIV infection in various age and gender groups of the Russian population at the beginning of XXI century]. Zdravookhranenie Rossiyskoy Federatsii. 2015; 5: 4-9. (In Russian)
5. Tsybikova E.B., Sabgayda T.P. Epidemiologiya tuberkuleza, sochetannogo s VICh-infektsiey [Epidemiology of HIV-associated tuberculosis]. Zdravookhranenie Rossiyskoy Federatsii 2012; 6: 7-11. (In Russian)
6. Burki T. Surveillance, co-infection, resistance: tuberculosis in Europe. Lancet Infect. Dis. 2011; II (5): 350-351.
7. Chamie G., Luetkemeyer A., Charlebois E., Havlir D.V. Tuberculosis as part of the natural history of HIV infection in developing countries. Clin. Infect. Dis. 2010; 50 (3): 245-54.
8. Gandhi N.R., Moll A., Sturm A.W., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368: 1575-1580.
9. Lawn S.D., Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr. Opin. HIV AIDS. 2009; 4: 325-333.
10. Telzak E.E., Sepkowitz K., Alpert P., Mann Heimer S., Medard F., El-Sadr W. et al. Multidrug-resistant tuberculosis in patients without HIV infection. N. Engl. J. Med. 1995; 333: 907-911.

Write Comment

Please keep the topic of messages relevant to the subject of the article. Personal verbal attacks will be deleted. Please don't use comments to plug your web site. Such material will be removed. Just ensure to *Refresh* your browser for a new security code to be displayed prior to clicking on the 'Send' button. Keep in mind that the above process only applies if you simply entered the wrong security code.
Name:
E-mail
Comment:
Code:*